Gepirone hydrochloride: preclinical pharmacology and recent clinical findings.
Yevich
J P
JP
Bristol-Myers Company, CNS Research, Pharmaceutical Research and Development Div., Wallingford, CT 06492.
Eison
M S
MS
Eison
A S
AS
Taylor
D P
DP
Yocca
F D
FD
VanderMaelen
C P
CP
Riblet
L A
LA
Robinson
D S
DS
Roberts
D L
DL
Temple
D L
DL
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D006801:Humans; D011743:Pyrimidines / Q000494:pharmacology* / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D011743:Pyrimidines; C039979:gepirone